Low-dose aspirin increases risk of major haemorrhages
23-day lock-out eliminated from iPLEDGE for certain patients
The US FDA and Bristol-Myers Squibb have notified physicians and pharmacists that the US labelling for warfarin is to be updated
ADRAC monitors reports of depression with ezetimibe
Avoid the 'triple whammy' says ADRAC
An alert has been issued for the potential mix-up between certain brand name medicines,
Current NSAID use associated with a modest increase in MI risk
Long-term rosiglitazone increases bodyweight, affects lipids
Neuropathy with leflunomide reported to ADRAC
The risk of myocardial infarction (MI) is similar with traditional NSAIDs and COX-2 inhibitors, except for naproxen which has a smaller risk,
Risk of CV disorders and diabetes with GnRH agonist use
Iodinated contrast media-related anaphylaxis: is prevention useful?
COX-2 inhibitors: 'risk-inducing' effect at higher doses
Aceclofenac
Antiretrovirals
Analgesics/low molecular weight heparins/ropivacaine
Benzalkonium chloride/levobunolol
Carbamazepine/phenytoin
Buprenorphine interaction
Carbamazepine
Carboplatin
Carboplatin
Ciclosporin/corticosteroids/mycophenolic acid
Ciclosporin/tacrolimus
Cyclophosphamide/etoposide
Diagnostic agents
Doxorubicin liposomal
Dapsone
Dopamine/norepinephrine
Doxorubicin liposomal
Efavirenz
Eptacog alfa
Escitalopram/venlafaxine
Fludarabine
Flucloxacillin/paracetamol
Hydromorphone
Herbal medicines
Imatinib
Fluoxetine/fluvoxamine
Interferon-α/interleukin-2
Immune globulin
Levobunolol
Measles virus vaccine live
Meloxicam
Oxaliplatin
Paracetamol overdose
Oxytocin
Pamidronic acid
Paracetamol/codeine phosphate
Paroxetine
Paroxetine
Psoralens
PEG 3350
Pregabalin
Sirolimus
Reboxetine
Simvastatin interaction
Tacrolimus
Sodium oxybate withdrawal
Solcoderm
Telithromycin
Tamoxifen
Triamcinolone
Timolol
Valproic acid
Vancomycin
Valproic acid